ConductScience.org, home

Paper39015166

A1C: Episode 3.

Aung NL. Clin Diabetes, 2024. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. A1C: Episode 3. Papers, record 39015166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39015166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A1C: Episode 3.
PubMed
Journal
Clin Diabetes
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.7, provisional
iCite
Revised in PubMed
2025-06-02
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aung NLNay Linnhttps://orcid.org/0000-0002-1468-8534

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18366922The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.N Engl J Med1993https://conductscience.org/library/papers/8366922PubMed
234170647Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.N Engl J Med2021https://conductscience.org/library/papers/34170647PubMed
336148880Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Diabetes Care2022https://conductscience.org/library/papers/36148880PubMed
416618895Long-term glycemic control and postoperative infectious complications.Arch Surg2006https://conductscience.org/library/papers/16618895PubMed
527222544Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.Diabetes Care2016https://conductscience.org/library/papers/27222544PubMed
622540912A clinical trial to maintain glycemic control in youth with type 2 diabetes.N Engl J Med2012https://conductscience.org/library/papers/22540912PubMed
727506222Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial.Diabetes Care2016https://conductscience.org/library/papers/27506222PubMed
828110911
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial.
Lancet Diabetes Endocrinol2017https://conductscience.org/library/papers/28110911PubMed
933651228Sodium-glucose cotransporter 2 inhibitors as an add-on therapy to insulin for type 1 diabetes mellitus: Meta-analysis of randomized controlled trials.Acta Diabetol2021https://conductscience.org/library/papers/33651228PubMed
1020150297
Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
Diabetes Care2010https://conductscience.org/library/papers/20150297PubMed
1120594588Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.Lancet2010https://conductscience.org/library/papers/20594588PubMed
1230457671A Model-Based Meta-Analysis of 24 Antihyperglycemic Drugs for Type 2 Diabetes: Comparison of Treatment Effects at Therapeutic Doses.Clin Pharmacol Ther2019https://conductscience.org/library/papers/30457671PubMed
1338230343A1C: Episode 1.Clin Diabetes2024https://conductscience.org/library/papers/38230343PubMed
148526459Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial.Ann Neurol1995https://conductscience.org/library/papers/8526459PubMed
1519625243Safe and simple emergency department discharge therapy for patients with type 2 diabetes mellitus and severe hyperglycemia.Endocr Pract2009https://conductscience.org/library/papers/19625243PubMed
169742976
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
Lancet1998https://conductscience.org/library/papers/9742976PubMed
1729029531Efficacy and safety of pramlintide injection adjunct to insulin therapy in patients with type 1 diabetes mellitus: a systematic review and meta-analysis.Oncotarget2017https://conductscience.org/library/papers/29029531PubMed
1820587587Effects of medical therapies on retinopathy progression in type 2 diabetes.N Engl J Med2010https://conductscience.org/library/papers/20587587PubMed
1933444163HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression.Diabetes Care2021https://conductscience.org/library/papers/33444163PubMed
2038694251A1C: Episode 2.Clin Diabetes2024https://conductscience.org/library/papers/38694251PubMed

See all 34 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
41140729Hypoglycemia.Clin Diabetes2025https://conductscience.org/library/papers/41140729PubMed
40741453Random Blood Glucose: Episode 2.Clin Diabetes2025https://conductscience.org/library/papers/40741453PubMed
40290826Random Blood Glucose: Episode 1.Clin Diabetes2025https://conductscience.org/library/papers/40290826PubMed
39829699Postprandial Plasma Glucose.Clin Diabetes2025https://conductscience.org/library/papers/39829699PubMed
39429450Plasma Glucose.Clin Diabetes2024https://conductscience.org/library/papers/39429450PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39015166

GET https://conductscience.org/api/papers/v1/39015166/references?page=2